Gmo Alternative Financials

GAAGX Fund  USD 17.48  0.11  0.63%   
You can make use of fundamental analysis to find out if Gmo Alternative Allo is mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to analyze and collect data for twelve available reported financial drivers for Gmo Alternative Allo, which can be compared to its competitors. The fund experiences a moderate downward daily trend and can be a good diversifier. Check odds of Gmo Alternative to be traded at $17.13 in 90 days.
  
Please note that you must use caution to infer results of funds future performance. Investment returns and principal value will fluctuate so that investors' shares, when sold, may be worth more or less than their original cost.

Gmo Alternative Fund Summary

Gmo Alternative competes with Gmo E, Gmo Trust, Gmo Treasury, Gmo Trust, and Gmo Emerging. The fund invests directly or indirectly in a combination of GMO investment strategies. The fund typically has exposure to many underlying strategies, and at any given time the fund may have significant exposure to a single or a few strategies. The fund gains exposure to commodities and some other asset classes by investing through a wholly-owned subsidiary advised by GMO, which does not receive any management or other fees for its services. It is non-diversified.
Specialization
Multistrategy, Large
InstrumentUSA Mutual Fund View All
ExchangeNMFQS Exchange
Business AddressGMO Trust
Mutual Fund FamilyGMO
Mutual Fund CategoryMultistrategy
BenchmarkDow Jones Industrial
Phone617 346 7646
CurrencyUSD - US Dollar

GMO Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Gmo Alternative's current stock value. Our valuation model uses many indicators to compare Gmo Alternative value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Gmo Alternative competition to find correlations between indicators driving Gmo Alternative's intrinsic value. More Info.
Gmo Alternative Allocation is one of the top funds in annual yield among similar funds. It also is one of the top funds in year to date return among similar funds creating about  3.80  of Year To Date Return per Annual Yield. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Gmo Alternative's earnings, one of the primary drivers of an investment's value.

Gmo Alternative Allo Systematic Risk

Gmo Alternative's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Gmo Alternative volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Execute Function
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Gmo Alternative Allo correlated with the market. If Beta is less than 0 Gmo Alternative generally moves in the opposite direction as compared to the market. If Gmo Alternative Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Gmo Alternative Allo is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Gmo Alternative is generally in the same direction as the market. If Beta > 1 Gmo Alternative moves generally in the same direction as, but more than the movement of the benchmark.
Gmo Alternative Allocation is one of the top funds in net asset among similar funds. Total Asset Under Management (AUM) of Multistrategy category is currently estimated at about 12.95 Billion. Gmo Alternative holds roughly 303.1 Million in net asset claiming about 2.34% of funds under Multistrategy category.

Gmo Alternative November 27, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Gmo Alternative help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Gmo Alternative Allocation. We use our internally-developed statistical techniques to arrive at the intrinsic value of Gmo Alternative Allocation based on widely used predictive technical indicators. In general, we focus on analyzing GMO Mutual Fund price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Gmo Alternative's daily price indicators and compare them against related drivers.

Other Information on Investing in GMO Mutual Fund

Gmo Alternative financial ratios help investors to determine whether GMO Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GMO with respect to the benefits of owning Gmo Alternative security.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum